Published date: 18 June 2020

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 22 July 2020

Contract summary

Industry

  • General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 33650000

Location of contract

North East, North West, Yorkshire and the Humber, East Midlands, East of England, London, South East, South West

Value of contract

£100,000,000

Procurement reference

tender_242901/862859

Published date

18 June 2020

Closing date

22 July 2020

Contract start date

1 April 2022

Contract end date

31 March 2032

Contract type

Supply contract

Procedure type

Competitive dialogue (above threshold)

Tenders are invited from pre-qualified suppliers after discussion of requirements and potential solutions.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Provision of a new antimicrobial to the NHS in England via a subscription-based payment model
The contract entered into pursuant to this procurement will be between the successful supplier and NHS England (the National Health Service Commissioning Board)
This procurement will be conducted by NHS England.
Organisations wishing to participate in the procurement must have at least one EU licensed antimicrobial that will have a UK launch dated on or between 1 January 2020 and 31 December 2020 and that is active against one or more pathogens on the World Health Organisation priority pathogen list.
There is no limit on the number of antimicrobials that an organisation can offer.
Contracts awarded pursuant to the procurement are for use by the Department of Health and Social Care, Public Health England, the NHS in England, and by private sector healthcare contractors and agents working on behalf of the aforementioned.
The successful supplier will be responsible for supply of the selected antimicrobial from 1st April 2022.
The duration of any contract awarded will be for an initial period of three (3) years, with the option to extend (by mutual agreement) for an additional period or periods up to seven (7) years.
Price is not the only award criterion and all criteria are stated only in the procurement documents
Further information is set out in the procurement documents which are available to download (see below for details).
NHS England intends to use the Bravo Solution e-tender portal in this procurement.
To Register and express interest - log on to the portal at: https://nhsengland.bravosolution.co.uk (registration and use of the website is free of charge)
OJEU Reference 2020/S 117-285216

More information

Links

Additional text

All procurement costs and liabilities incurred by bidders shall be the sole responsibility of bidders.

The contracting authority reserves the right to award in whole or in part.

The contracting authority reserves the right to annul the procurement process and not award any contract.

All documents to be priced in GBP and all payments made in GBP.

In relation to section II.2.10 of this notice, variants will be accepted to the extent permitted (if at all) in the invitation to participate in dialogue (ITPD) documents.

The successful supplier will be required to deliver community benefits in support of the contracting authority's social, economic and environmental objectives. Accordingly, contract performance conditions may relate to social, economic and environmental considerations.

About the buyer

Contact name

Mark Perkins

Address

Skipton House, 80 London Road
London
SE1 6LH
England

Email

mark.perkins@nhs.net